Journal: | Revista de la Asociación Mexicana de Medicina Crítica y Terapia Intensiva |
Database: | PERIÓDICA |
System number: | 000351434 |
ISSN: | 0187-8433 |
Authors: | Fortuna Custodio, Jorge Alberto1 Rivera Marchena, José Rosendo1 Cervantes Retana, Consuelo1 Fierro Flores, Lauro L1 Roldan García, Arcelia Minerva1 Navarro Gutiérerz, Juan Manuel1 Cedillo Torres, Héctor Ignacio1 |
Institutions: | 1Secretaría de Salud del Distrito Federal, Hospital General Xoco, México, Distrito Federal. México |
Year: | 2012 |
Season: | Jul-Sep |
Volumen: | 26 |
Number: | 3 |
Pages: | 127-151 |
Country: | México |
Language: | Español |
Document type: | Estadística o encuesta |
Approach: | Analítico |
Spanish abstract | Carbapemenes (94%), cefotaxima (80.80), cefepima, (80.98%). Gram negativo no enterobacteria; carbapemenes 93% monofl oxacino 90%, cefotaxima, ceftriaxona, quinolonas y cefepima 85%. Discusión y conclusiones: Las incidencia de IN es similar a otros estudios. En México, no existen estudios que reflejen el perfil epidemiológico en las UCI’s, por lo que se pretende que el proyecto PECIN se aplique a nivel nacional |
English abstract | It is recognized that the UCI’s have a higher incidence of IN, a result of collecting a greater number of risk factors, costs reach $ 2,000 day. With effect: NAV, 45%, 23.3% UTI-SV, BP-CV 23.2. 54.9% are caused by Gramnegative, Gram-positive 32.4% and 12.2% fungi. Caused by P. aeruginosa (13.1%), E. coli (11.3%), S. aureus (7.2%), S. epidermidis (7.1%) and Candida albicans (6.0%). Objective: The purpose of this report is to analyze the epidemiological behavior of NIs in the ICU and to identify risk factors, mortality, antibiotic sensitivity and cost of care. Patients and methods: We studied 1,771 patients: Inclusion criteria: a) stay > 48 hours, b) VM> 48 hours, c) Time of vascular catheterization, bladder, and so on. d) And surgical wounds drains, f) State of shock g) Prior antimicrobial therapy. Exclusion criteria: a) Evidence in outside UCI, b) Transferred within 48 hours. Elimination criteria: a) Community or nosocomial infection in hospital or another hospital, b) Death within 48 hours c) Transfer to another unit and d) Without making crops or report. Results: IN was observed in 34.66% patients and 12.1 days watching/stay, cost $ 28,226.63 care/day ($2192.64 U.S. dollars). Identifi ed risk factors: CV 89.84%, 49.90% VM, severity, shock and coagulopathy 45.78%, 88.54%. Past infection; sedation > 5 days 90.74%, stay > 3 days 96.75%. The NAV 40.68%, HQA-CV 8.35 and BP 6.07%. The 68.62-negative are caused by gram-positive and 31.37% by frequency: P. aeruginosa (24.73%), Staphylococcus aureus (20.52%), A. baumannii (14.52%), K. pneumoniae (7.52%), E. cloacae (6.84%), E. coli (4.78%) and S. marcescens 4.0%. Sensitivity: -Positive: carbapemenes (91.86%), teicoplanin/90.70% linezolid, vancomycin and gentamicin 85%. Gram-negative enterobacteria: Carbapemenes (94%), cefotaxime (80.80), Cefepima (80.98%). Gram-negative enterobacteria not: carbapemenes 93%, monofloxacino 90%, cefotaxime, ceftriaxone, quinolones and Cefepima 85%. Discussion and.. |
Disciplines: | Medicina |
Keyword: | Hospitales, Microbiología, Salud pública, Cuidados intensivos, Neumonía, Infección hospitalaria, Bacteremia, Vías urinarias, Heridas quirúrgicas, Drenaje quirúrgico, Mortalidad, Factores de riesgo |
Keyword: | Medicine, Hospitals, Microbiology, Public health, Intensive care, Pneumonia, Nosocomial infections, Bacteremia, Urinary tract, Surgical wounds, Surgical drainage, Mortality, Risk factors |
Full text: | Texto completo (Ver PDF) |